MedWatch

Danish bank: Lost appeal case paves way for new compensation claims against Lundbeck

Senior Equity Analyst at Sydbank Søren Løntoft Hansen estimates that Lundbeck might risk getting more compensation claims after the firm lost an appeal case at the European Court of Justice.

Photo: Sydbank/PR

Danish pharmaceutical company Lundbeck may being subjected to a series of compensation claims after losing an appeal case at the European Court of Justice on Thursday.

So estimates Senior Equity Analyst Søren Løntoft Hansen from the Danish bank Sydbank.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs